Literature DB >> 18652869

Microglial activation in schizophrenia and minocycline treatment.

Kenji Hashimoto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18652869     DOI： 10.1016/j.pnpbp.2008.06.012

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN： 0278-5846            Impact factor:   5.067


× No keyword cloud information.
  10 in total

Review 1.  The "quad-partite" synapse: microglia-synapse interactions in the developing and mature CNS.

Authors:  Dorothy P Schafer; Emily K Lehrman; Beth Stevens
Journal:  Glia       Date:  2012-07-24       Impact factor: 7.452

Review 2.  Viral infection, inflammation and schizophrenia.

Authors:  Rachel E Kneeland; S Hossein Fatemi
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-02-10       Impact factor: 5.067

3.  Interferon-gamma-inducible kynurenines/pteridines inflammation cascade: implications for aging and aging-associated psychiatric and medical disorders.

Authors:  Gregory F Oxenkrug
Journal:  J Neural Transm (Vienna)       Date:  2010-09-02       Impact factor: 3.575

4.  Adjunctive Minocycline in Clozapine-Treated Schizophrenia Patients With Persistent Symptoms.

Authors:  Deanna L Kelly; Kelli M Sullivan; Joseph P McEvoy; Robert P McMahon; Heidi J Wehring; James M Gold; Fang Liu; Dale Warfel; Gopal Vyas; Charles M Richardson; Bernard A Fischer; William R Keller; Maju Mathew Koola; Stephanie M Feldman; Jessica C Russ; Richard S E Keefe; Jennifer Osing; Leeka Hubzin; Sharon August; Trina M Walker; Robert W Buchanan
Journal:  J Clin Psychopharmacol       Date:  2015-08       Impact factor: 3.153

5.  Eosinophil chemotactic chemokine profilings of the brain from permissive and non-permissive hosts infected with Angiostrongylus cantonenis.

Authors:  Shuting Li; Fan Yang; Pengyu Ji; Xin Zeng; Xiaoying Wu; Jie Wei; Lisi Ouyang; Jinyi Liang; Huanqin Zheng; Zhongdao Wu; Zhiyue Lv
Journal:  Parasitol Res       Date:  2014-02       Impact factor: 2.289

Review 6.  Neuroimmunological aberrations and cerebral asymmetry abnormalities in schizophrenia: select perspectives on pathogenesis.

Authors:  Ganesan Venkatasubramanian; Monojit Debnath
Journal:  Clin Psychopharmacol Neurosci       Date:  2014-04-24       Impact factor: 2.582

Review 7.  Targeting of α7 Nicotinic Acetylcholine Receptors in the Treatment of Schizophrenia and the Use of Auditory Sensory Gating as a Translational Biomarker.

Authors:  Kenji Hashimoto
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

Review 8.  The role of microglia in neuropsychiatric disorders and suicide.

Authors:  Ralf Brisch; Szymon Wojtylak; Arthur Saniotis; Johann Steiner; Tomasz Gos; Jaliya Kumaratilake; Maciej Henneberg; Rainer Wolf
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2021-09-30       Impact factor: 5.760

9.  Minocycline as adjunct therapy for a male patient with deficit schizophrenia.

Authors:  Xiaohua Chen; Zhenzhen Xiong; Zhixiong Li; Yali Yang; Zhanying Zheng; Yonghong Li; Yan Xie; Zhe Li
Journal:  Neuropsychiatr Dis Treat       Date:  2018-10-12       Impact factor: 2.570

Review 10.  Prefrontal GABAergic Interneurons Gate Long-Range Afferents to Regulate Prefrontal Cortex-Associated Complex Behaviors.

Authors:  Sha-Sha Yang; Nancy R Mack; Yousheng Shu; Wen-Jun Gao
Journal:  Front Neural Circuits       Date:  2021-07-12       Impact factor: 3.492
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.